Insulin analogues in the treatment of diabetes in pregnancy

scientific article

Insulin analogues in the treatment of diabetes in pregnancy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1590/S0004-27302012000700001
P3181OpenCitations bibliographic resource ID566619
P698PubMed publication ID23108744

P50authorMarilia Brito GomesQ88048537
P2093author name stringGomes MB
Mattar R
Guedes MF
Montenegro Junior RM
Negrato CA
Von Kostrisch LM
P2860cites workPregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog).Q30879494
Survey of glargine use in 115 pregnant women with Type 1 diabetesQ33316172
Insulin glargine safety in pregnancy: a transplacental transfer studyQ33556840
Insulin aspart: a new rapid-acting insulin analogQ34122518
Effect of treatment of gestational diabetes mellitus on pregnancy outcomesQ34558501
Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based studyQ34805336
Intermediate metabolism in normal pregnancy and in gestational diabetes.Q35184288
Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomesQ35198990
Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?Q36092959
Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort studyQ36245629
Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994.Q36245644
Treatment with insulin and its analogs in pregnancies complicated by diabetesQ36862933
Perinatal outcomes associated with the use of glargine during pregnancyQ37035503
Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research GroupQ37075365
Insulin treatment in diabetic pregnancyQ37144833
Insulin glargine versus neutral protamine Hagedorn insulin for treatment of diabetes in pregnancyQ37315640
Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the NetherlandsQ37513861
Safety of insulin glargine use in pregnancy: a systematic review and meta-analysisQ37826022
Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetesQ37873889
Randomized trial of human versus animal species insulin in diabetic pregnant women: improved glycemic control, not fewer antibodies to insulin, influences birth weightQ41101517
Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomiaQ41204557
Metabolic and immunologic effects of insulin lispro in gestational diabetesQ41689564
Risk factors and obstetric complications associated with macrosomiaQ43540877
Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy.Q43903152
Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitusQ44126489
Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitusQ44262770
Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lisproQ44381386
Transfer of insulin lispro across the human placenta: in vitro perfusion studiesQ44418797
Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant womenQ44616167
A randomised controlled trial of insulin lispro given before or after meals in pregnant women with type 1 diabetes--the effect on glycaemic excursionQ44941526
Threshold values of maternal blood glucose in early diabetic pregnancy--prediction of fetal malformations.Q45189752
Maternal mortality in type 1 diabetesQ46352960
Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control studyQ46357269
Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005.Q46618833
Fetal and neonatal outcomes of diabetic pregnanciesQ47578817
Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women.Q53199148
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectpreproinsulinQ7240673
gestational diabetesQ126691
P304page(s)405-14
P577publication date2012-10-01
P1433published inArquivos Brasileiros de Endocrinologia e MetabologiaQ15751181
P1476titleInsulin analogues in the treatment of diabetes in pregnancy
P478volume56

Reverse relations

cites work (P2860)
Q30238619Different insulin types and regimens for pregnant women with pre-existing diabetes.
Q24186739Insulin for the treatment of women with gestational diabetes
Q46301748Insulin for the treatment of women with gestational diabetes.
Q33719410Is a low level of free thyroxine in the maternal circulation associated with altered endothelial function in gestational diabetes?
Q37031287PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns
Q93167299Successful Outcomes with Insulin Degludec in Pregnancy: A Case Series
Q57688911Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews
Q26779412Use of Insulin Lispro Protamine Suspension in Pregnancy

Search more.